Valuation for a Specialty Finance Company (Equity DCF or DDM?)

A client of ours is looking to invest a significant minority stake in a diversified specialty finance company. Half of their income comes from purchasing and selling factoring receivables (so like most non-banks, the company is highly leveraged, since they need the debt to purchase the receivables) and the other half is fee-based income. In this case, I think it's best to calculate the equity value, instead of EV, but I was wondering which is more common in the case of a non-bank, specialty finance company. There's no regulated capital like banks, so if I were to do DDM, then I would also have to come up with a rationale on whether to set a minimum capital ratio for the projections or just have all of the Net Income back into the dividends issued. Equity DCF (FCFE) sounds more reasonable for non-banks but projecting the debt servicing/capex for FCFE sounds difficult (please correct me if I'm wrong).

If anyone has done valuation of a non-bank/specialty finance company, could you please explain how you valued the company? Also, if anyone has ever done an lbo model for a specialty finance company, any explanation regarding differences between that and a regular company would be much appreciated.

Any advice, tips, etc. would be helpful. Thanks in advance!

2 Comments
 
Best Response

You want to use a DDM for specialty finance companies(BS lenders).

If it is a more mature company I would look at the historical debt to equity ratio and keep that constant. Another option would be to look at the debt covenants and figure it out that way.

However you figure out what the minimum equity needed you will need to make sure that base is satisfied and pay the rest of the earnings out as a dividend.

I have only built out on full lbo model for a spec fin company so I am not sure if my experience would be helpful but my one point of advice is to pay attention to the debt needed to run the business and the amount of debt a sponsor can actually put on the business.

 

Doloremque iusto enim incidunt est. Et ut aperiam nihil voluptatum qui. Sint hic quos at accusantium molestiae architecto. Facilis et et consequatur et autem. Beatae ut fuga qui quibusdam consequatur.

Ut quae qui incidunt error. Modi doloremque a ut necessitatibus aut. Deleniti dicta qui voluptatem. Cupiditate eveniet maiores laboriosam possimus id tempora.

Consequatur assumenda est dolor ad in esse. Facere voluptatem enim quis. Autem magni ullam consectetur ut quo quos. Et est et iusto non et. Dolorem animi nesciunt sequi et ducimus inventore tenetur.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”